The Incidence and Alliance of Metabolic Syndrome with Cardiovascular Risk Markers among Kodavas

HTML  Download Download as PDF (Size: 1073KB)  PP. 158-166  
DOI: 10.4236/ojemd.2014.46016    2,882 Downloads   4,341 Views  Citations

ABSTRACT

Background: Metabolic syndrome is the major cause for life threatening disorders such as cardiovascular diseases and type 2 diabetes. These disorders are associated with hyperuricemia and the number is growing among the urban population. Methods: A cross sectional study was done among Kodava population by conducting health camps in Mysore district. Metabolic syndrome was defined according to Joint Interim Statement criteria. Anthropometry was done and blood pressure readings were noted. Clinical markers like fasting glucose, triglyceride, high density lipoprotein, CVD markers and uric acid levels were analyzed. Results: The prevalence of metabolic syndrome was 60.77% and the utmost occurrence was in 41 - 60 age groups. Women were more affected than men (31.58%) and MetS became pronounced with advance of age. Biochemical levels of C-reactive protein, ApolipoproteinB/ApolipoproteinA1 ratio and uric acid wereraised (P < 0.05) and the severity correlated with the number of components of metabolic syndrome. Conclusions: This study helped in identifying new subjects with metabolic syndrome wherein, abdominal obesity was the most common abnormality followed by elevated fasting glucose. Female subjects and subjects with increased waist circumference along with mid aged people are more susceptible to MetS which amplified their CVD risk factors and hyperuricemic conditions. Life style modifications and therapeutic approach are critical prerequisite. However, there is an urgent need for further health camps for the awareness, and prevention of MetS and its associated risk factors among Kodavas.

Share and Cite:

Lokanath, D. , Chandrashekariah, S. , Xaviour, D. and Rao, J. (2014) The Incidence and Alliance of Metabolic Syndrome with Cardiovascular Risk Markers among Kodavas. Open Journal of Endocrine and Metabolic Diseases, 4, 158-166. doi: 10.4236/ojemd.2014.46016.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.